284 filings
Page 7 of 15
8-K
ig844 uta3cl4
14 Aug 17
Galena Biopharma Reports Second Quarter 2017 Financial Results
12:00am
8-K
dic0gd6 qb2i8
8 Aug 17
Galena Biopharma Enters into Merger Agreement with SELLAS Life Sciences Group
12:00am
8-K
4eg2ugvb4jf9 tyb
8 Aug 17
Regulation FD Disclosure
12:00am
8-K
qlvfoo 7vkc5
28 Jul 17
Unregistered Sales of Equity Securities
12:00am
8-K
kaq57a4zp41sk1
11 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
ezr8n3auz484aoiptz
6 Jul 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
9fck f8qykyos8lzu
12 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ruvzk76pb fm54zrn
6 Jun 17
Termination of a Material Definitive Agreement
12:00am
8-K
ejor 8vdgpfywsu9
10 May 17
Galena Biopharma Reports First Quarter 2017 Financial Results
12:00am
8-K
iwdfzozbway4j
2 May 17
Unregistered Sales of Equity Securities
12:00am
8-K
0eygt62ks1kwi6c
3 Apr 17
Entry into a Material Definitive Agreement
12:00am
8-K
uusv0m5qf lmuqvugu
28 Mar 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
dvve sjdc
23 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
h7v8y vwbpajy03v
15 Mar 17
Galena Biopharma Reports Fourth Quarter and Year End 2016 Financial Results and Provides a Corporate Update
12:00am
8-K
u44brg91 p22i
13 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
h6k4c4p4x79af7ea826
21 Feb 17
Galena Biopharma Board of Directors Appoints Stephen F. Ghiglieri as Interim Chief Executive Officer
12:00am
8-K
xsy rjc9i9cp6ie
10 Feb 17
Galena Biopharma Announces Proposed Public Offering of Common Stock and Warrants
12:00am
8-K
dir1ww7k05sw css
7 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
839h657j1sazzcd
31 Jan 17
Galena Biopharma Announces the Resignation of its President and Chief Executive Officer and the Evaluation of Strategic Alternatives
12:00am
8-K
bgpvbj
9 Jan 17
Other Events
12:00am